Discover the best American‑made brands offering high‑quality products crafted in the USA. Shop brands across cookware, bedding, home goods and more.

The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have implications for the legality of 'skinny labels,' which can help generic drugmakers ...

aNational Health Commission Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China bSchool of Public Health, National Vaccine ...

The Pelicans need better guard play, more shooting and more defense.

Buying a new Cadillac Escalade is supposed to be the definition of peace of mind. Instead, for one Florida woman, it turned ...

A US Supreme Court fight over how branded drugs’ makers must plead induced infringement in “skinny-label” patent suits could both reshape the pharmaceutical industry’s financial and legal calculus and ...

The court’s review of a high-profile dispute could offer clarity on a grey area for pharma companies and generic drug makers, but also prompt fresh questions.

The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drug maker Hikma that puts so-called “skinny labels” back in the spotlight. The high court has agreed to make the ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. It’s difficult to explain the Blockbuster experience to those ...

The US Supreme Court will hear generic maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that it induced doctors and pharmacists to prescribe its generic heart medicine for ...